PD31-11 CONDITIONAL PROBABILITY SURVIVAL ANALYSIS OF PATIENTS WITH MALIGNANT ADRENAL PHEOCHROMOCYTOMAS

Wenjun Xiao,Yu Zhu,Yao Zhu,Dingwei Ye

DOI: https://doi.org/10.1097/ju.0000000000000895.011

2020-01-01

Abstract:You have accessJournal of UrologyAdrenal (PD31)1 Apr 2020PD31-11 CONDITIONAL PROBABILITY SURVIVAL ANALYSIS OF PATIENTS WITH MALIGNANT ADRENAL PHEOCHROMOCYTOMAS Wenjun Xiao*, Yu Zhu, Yao Zhu, and Dingwei Ye Wenjun Xiao*Wenjun Xiao* More articles by this author , Yu ZhuYu Zhu More articles by this author , Yao ZhuYao Zhu More articles by this author , and Dingwei YeDingwei Ye More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000000895.011AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Malignant Pheochromocytoma (PHEO) may be commom malignant tumor of adrenal medulla. The disease may have different behavior stratified by different prognostic factors. Besides, disease prognosis is not constant over time; consequently, the conditional survival (CS) of patients with malignant PHEO needs to be evaluated. CS was defined as the probability of surviving for an additional period on the condition that a patient had already survived for a designated length of time. METHODS: The SEER database was queried for patients aged >18 years diagnosed with malignant PHEO between 2004 and 2015. Demographic, clinical and pathologic information included patient gender, age at diagnosis, race, year of diagnosis, surgery, laterality, clinical stage, metastasis at diagnosis and survival status as of December 31, 2016. Cases with more than one primary malignant tumors, or unavailable follow-up information were excluded. Survival analysis were performed. Conditional survival, CS(y/x), is the probability of surviving an additional y years, S(x+y), given that the patient has already survived x years, S(x). The mathematical definition of CS can be expressed as: CS(y/x)=S(x+y)/S(x). RESULTS: A total of 210 patients were selected, and 64 cases had metastatic disease at diagnosis. In univariate analysis, factors associated with lower overall survival (OS) included older age, diagnosed with distant metastases,and failure to undergo any surgery. Cox proportional hazards regression analysis showed that these factors independently associated with higher overall mortality. These factors were also independently associated with cancer-specific survival (CSS). Patients diagnosed with metastatic disease had a poor prognosis with a median OS and CSS of 19 months, while patients with localized disease had a longer median OS of 131 months. During the first 5 years after their initial diagnosis, the 1-year CS of patients who had survived >24 months increased to approximately 90%, while OS decreased progressively from about 70%. The gains in 1-year CS over time were more pronounced in patients with poor prognostic factors. These differences in 1-year CS between the different prognostic factor groups decreased with time from diagnosis, or even disappeared. CONCLUSIONS: These findings provided a new perspective for understanding the prognosis of malignant PHEO. Source of Funding: no © 2020 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 203Issue Supplement 4April 2020Page: e634-e634 Advertisement Copyright & Permissions© 2020 by American Urological Association Education and Research, Inc.MetricsAuthor Information Wenjun Xiao* More articles by this author Yu Zhu More articles by this author Yao Zhu More articles by this author Dingwei Ye More articles by this author Expand All Advertisement PDF downloadLoading ...